Amplification of FGFR1 located in chromosome 8p11-12 in 10-15% of breast cancer [8, 9], has been correlated with FGFR1 overexpression and poor overall survival, particularly in estrogen receptor-positive (ER+) breast cancer [8–10]. Here, FGFR1 is linked to breast carcinoma.